Unity Total Knee System, Unity Knee Cementless CR Femur
Corin, Ltd. · Decision date Sep 17, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-17 for K261275, a traditional 510(k) submitted by Corin, Ltd. of Cirencester, GB, and received on 04/17/2026. The device is listed as the Unity Total Knee System, Unity Knee Cementless CR Femur, under regulation 888.3565 with classification product code MBH and subsequent product code JWH; the review panel and medical specialty are both orthopedic. SESE denotes clearance rather than PMA approval.
The record identifies the submission as a cementless, porous-coated, semi-constrained patello/femorotibial knee prosthesis, but the public fields do not specify which components, sizes or design changes distinguish this femur from prior Corin knee submissions, nor the predicate device relied upon. The page also notes the review was not conducted by a third party, was not a combination product, and had no authorized predetermined change control plan. No summary statement content, indications, or clinical performance data appear in the retrieved material, so the basis for the equivalence determination remains unknown from these fields.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261275
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Corin, Ltd.
- Product code
- MBH
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer.
- Applicant
- Corin, Ltd.
- Product code
- MBH
- FDA device class
- 2
FDA decision timeline
K261275 received
Application receipt date recorded by FDA.
K261275 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MBH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LANDMARK Total Knee SystemK261462 | Smith & Nephew, Inc. | 510(k) clearance | Sep 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Corin, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Cirencester
Sources and methodology
- Original FDA record: K261275
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records